NCT01577914View on ClinicalTrials.gov

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Fasting State
Interventions
DRUG

Carvedilol Tablets USP 12.5 mg

12.5mg tablet once a day

DRUG

Carvedilol

12.5mg tablet once a day

Trial Locations (1)

Unknown

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY